Convermat Corporation Revenue and Competitors

Great Neck, NY

Location

N/A

Total Funding

Paper

Industry

Employee Data

  • Convermat Corporation has 29 Employees.(i)
  • Convermat Corporation grew their employee count by 4% last year.

Convermat Corporation's People

NameTitleEmail/Phone
1
Chief Financial Officer - CFOReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
SVP Business DevelopmentReveal Email/Phone
4
VP - Int'l SalesReveal Email/Phone
5
VP SalesReveal Email/Phone
6
Operations ManagerReveal Email/Phone
7
Executive AssistantReveal Email/Phone
8
Executive AssistantReveal Email/Phone
9
Staff AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A3210%N/AN/A
#2
N/A445%N/AN/A
#3
$15M145-1%N/AN/A
#4
$3.5M632%N/AN/A
#5
N/A327%N/AN/A
#6
$15M277-3%N/AN/A
#7
$35M32-6%N/AN/A
#8
N/A346%N/AN/A
#9
N/A22-12%N/AN/A
#10
$7.5M9027%N/AN/A
Add Company

What Is Convermat Corporation?

Led by Shaw and Frank Shahery, Convermat is the leading global supplier of parent rolls of tissue doing business in more than 80 countries worldwide. Our unparalleled market intelligence and strong network of strategic alliances, resources, and insider knowledge will help your business grow and achieve higher profits. Since 1976, our speed, reliability, and integrity has helped us partner with more global tissue players than any other company. Our mission is to serve our clients as their enduring trusted source and supplier. We enable our clients to achieve their goals and become partners in their future success. We stand for honesty, integrity, and social responsibility. We offer a full range of grades in both tissue and nonwovens. Feel free to visit our website to learn more and find our contact information.

keywords:N/A

N/A

Total Funding

29

Number of Employees

N/A

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M29-12%N/A
#2
$3.6M307%N/A
#3
$8.3M32-3%N/A
#4
$6.5M3310%N/A
#5
$8.7M33-6%N/A